TCF4 and hepatocellular carcinoma: The results from the current study revealed that in HCC cells the β-catenin/TCF4 complex played critical roles in doxorubicin-induced EMT, and disruption of the β-catenin/TCF complex by PKF 118-310 could prevent the EMT process.